Hasta GörüşleriProf. Dr. Yonca Aydın AkovaProf. Dr. Yonca Aydın Akova Göz Sağlığı ve Hastalıkları Uzmanı

Akademik Yayınlar

  1. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop.
  2. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
  3. Optic disk neovascularization in a patient with cytomegalovirus retinitis associated with renal transplantation.
  4. Clinical features and keratoplasty results in keratoconus complicated by acute hydrops.
  5. Granulomatous anterior uveitis in a patient with CREST syndrome.
  6. Atopic keratoconjunctivitis.
  7. Bilateral corneal infiltrates and uveitis in a pediatric patient with presumed ocular sarcoidosis.
  8. Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease.
  9. Atypical ocular atopy.
  10. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.
  11. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis.
  12. Referral patterns of uveitis in a tertiary eye care center.
  13. Ocular involvement in siblings with familial mediterranean fever.
  14. Cataract surgery in patients with sarcoidosis-associated uveitis.
  15. Microbial keratitis following penetrating keratoplasty.
  16. Penetrating keratoplasty in cicatrizing conjunctival diseases.
  17. Penetrating keratoplasty in atopic keratoconjunctivitis.
  18. Late bleb-related endophthalmitis after trabeculectomy with mitomycin C.
  19. Pseudotumor cerebri secondary to dural sinus thrombosis in neurosarcoidosis.
  20. Phacoemulsification and intraocular lens implantation in a patient with Mooren's ulcer.
  21. Results of cataract surgery in renal transplantation patients.
  22. Decision-making in second-eye cataract surgery: can presence of Pulfrich phenomenon help?
  23. Recurrent macular corneal dystrophy following penetrating keratoplasty.
  24. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
  25. Complications of extracapsular cataract surgery in chronic renal failure patients.
  26. Management of hypotony maculopathy and a large filtering bleb after trabeculectomy with mitomycin C: success with argon laser therapy.
  27. Scleromalacia following trabeculectomy with intraoperative mitomycin C.
  28. Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study.
  29. Ophthalmoparesis, papillitis and premacular hemorrhage in a case with endocarditis: a rare presentation of Brucellosis.
  30. Glare disability in patients with hydrophilic and hydrophobic acrylic intraocular lens implants.
  31. Pediatric Ocular Acne Rosacea: Clinical Features and Long Term Follow-Up of Sixteen Cases.
  32. Comparison of Mix-and-Match Implanted Bifocal IOLs and Bilateral Implanted Trifocal IOLs After Femtosecond Laser-Assisted Cataract Surgery.
  33. Role of corneal nerves in ocular surface homeostasis and disease.
  34. Controlled Adverse Environment Chambers in Dry Eye Research.
  35. Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis.
  36. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting.
  37. Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting.
  38. Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis.
  39. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.
  40. Central corneal thickness in type II diabetes mellitus: is it related to the severity of diabetic retinopathy?
  41. The Results of Toric Intraocular Lens Implantation in Patients With Cataract and High Astigmatism After Penetrating Keratoplasty.
  42. Suramin, Genistein and Collagen Matrix (DuraGen) for Delayed Adjustment after Strabismus Surgery: Which One is Best?
  43. Visual Outcomes at 12 Months in Patients Following Implantation of a Diffractive Multifocal Intraocular Lens.
  44. Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?
  45. Vascularization of conjunctival autografts in pterygium surgery: comparison of fibrin glue with sutures.
  46. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
  47. Subconjunctival bevacizumab in the impending recurrent pterygia.
  48. Risk factors for intraocular pressure rise following phacoemulsification.
  49. Astigmatic changes following pterygium removal: comparison of 5 different methods.
  50. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
  51. The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization.
  52. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.
  53. Tear osmolarity in unilateral pseudoexfoliation syndrome.
  54. Diurnal variation of the tear osmolarity in normal subjects measured by a new microchip system.
  55. Recurrent iris cyst discharge.
  56. Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homonymous hemianopsia.
  57. Limbal stem cell transplantation with amniotic membrane for the treatment of uniocular chemical burn in children.
  58. Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a developing nation.
  59. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
  60. Nasolacrimal duct obstruction: clinicopathologic analysis of 205 cases.
  61. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
  62. Toxic anterior segment syndrome presenting as isolated cystoid macular edema after removal of entrapped ophthalmic ointment.
  63. Severe corneal changes following intravitreal injection of bevacizumab.
  64. Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation.
  65. Management of facial disfigurement in orbitotemporal neurofibromatosis.
  66. Comparison of alloplast materials in experimental extraocular muscle surgery.
  67. Impression cytology and ocular surface characteristics in patients with seborrhoeic dermatitis.
  68. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
  69. Silicone intubation with the Ritleng method using intranasal endoscopy to treat congenital nasolacrimal duct obstruction.
  70. Aqueous humor and plasma levels of vascular endothelial growth factor and nitric oxide in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
  71. Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery.
  72. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients.
  73. Amniotic membrane transplantation using fibrin glue in pterygium surgery: a comparative randomised clinical trial.
  74. Clinical factors associated with floppy iris signs: a prospective study from two centers.
  75. Intraocular pressure after phacoemulsification in eyes with pseudoexfoliation.
  76. p53 expression in pterygium in two climatic regions in Turkey.
  77. Induction of apoptosis of rabbit corneal endothelial cells by preservative-free lidocaine hydrochloride 2%, ropivacaine 1%, or levobupivacaine 0.75%.
  78. Ciliary body toxicity of subconjunctival suramin compared with mitomycin-C in the rabbit eye: determining the toxic concentration.
  79. Conjunctival impression cytology and tear-film changes in patients with familial Mediterranean fever.
  80. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
  81. Demographic and clinical features of uveitis in tertiary centers in Turkey.
  82. Effect of corneal thickness on intraocular pressure measurements with the Pascal dynamic contour, Canon TX-10 non-contact and Goldmann applanation tonometers in healthy subjects.
  83. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
  84. Intravitreal injection of bevacizumab in Eales disease.
  85. One surgeon's experience with hydrophilic and hydrophobic intraocular lens implantation using the Monarch II injector.
  86. Rhombencephalosynapsis associated with infantile strabismus.
  87. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.
  88. Basosquamous carcinoma of the lacrimal sac: a case report.
  89. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
  90. Periorbital necrobiosis lipoidica diabeticorum: case report.
  91. Comparative clinical trial of topical anaesthetic agents for cataract surgery with phacoemulsification: lidocaine 2% drops, levobupivacaine 0.75% drops, and ropivacaine 1% drops.
  92. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
  93. Astigmatism induced by oblique clear corneal incision: right vs. left eyes.
  94. Comparison of ultrasonic pachymetry with Orbscan in corneal haze.
  95. Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.
  96. Effect on astigmatism of the location of clear corneal incision in phacoemulsification of cataract.
  97. Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
  98. Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome.
  99. Evaluation of ocular surface changes in a rabbit dry eye model using a modified impression cytology technique.
  100. The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.
  101. Retinal arterial macroaneurysm rupture following fundus fluorescein angiography and treatment with Nd:YAG laser membranectomy.
  102. The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.
  103. Efficiency of Rarebit perimetry in the evaluation of homonymous hemianopia in stroke patients.
  104. Vascularization is more delayed in amniotic membrane graft than conjunctival autograft after pterygium excision.
  105. Photic retinopathy after cataract surgery in diabetic patients.
  106. [Papilloedema and brain abscess associated with isolated left superior vena cava draining in to the left atrium].
  107. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.
  108. Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epidermolysis bullosa.
  109. Risk factors in the development of mild and severe retinopathy of prematurity.
  110. Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics.
  111. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.
  112. Bilateral synchronous primary orbital lymphoma.
  113. Relationship between optokinetic nystagmus response and recognition visual acuity.
  114. [Hemicentral retinal artery occlusion associated with moyamoya syndrome].
  115. Opportunistic posterior uveal infections in renal transplant patients.
  116. Spontaneous posterior dislocation of both lenses in a patient with Marfan's syndrome: 17 years without complications.
  117. Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography.
  118. Smoking associated with damage to the lipid layer of the ocular surface.
  119. Clinical results of phacoemulsification in patients with uveitis.
  120. Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a haemodialysis patient.
  121. Repeat LASIK after penetrating keratoplasty for repair of a corneal perforation from previous LASIK.
  122. Oral anticoagulant therapy, endocapsular hematoma, and neodymium:YAG capsulotomy.
  123. Tear clearance measurement in patients with dry eye syndrome using quantitative lacrimal scintigraphy.
  124. Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy.
  125. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease.
  126. Myositis and scleritis associated with Behcet's disease: an atypical presentation.
  127. Indocyanine green angiography in ocular tuberculosis.
  128. Scleritis associated with sarcoidosis.
  129. Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis.
  130. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliation.
  131. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
  132. An atypical case of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome.
  133. Refractive outcome of single running suture adjustment in penetrating keratoplasty.
  134. Choroidal abscess due to nocardial infection in a renal allograft recipient.
  135. Topical cyclosporine in the management of shield ulcers.
  136. Ethambutol-induced optic neuropathy in a patient with pituitary macroadenoma: case report.
  137. Spontaneous rupture of the anterior lens capsule combined with macular hole in a child with Alport's syndrome.
  138. Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behçet's disease.
  139. Duane's retraction syndrome in association with retinitis pigmentosa.
  140. Posterior scleritis in psoriatic arthritis.
  141. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women.
  142. The effect of hemodialysis on visual field test in patients with chronic renal failure.
  143. Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion.
  144. Ocular toxoplasmosis presenting as neuroretinitis: report of two cases.
  145. Trypan-blue-assisted capsulorhexis for trainee phacoemulsification surgeons.
  146. Anterior segment indocyanine green angiography in pterygium surgery with conjunctival autograft transplantation.
  147. Macular ischaemia in Behçet's disease.
  148. Pyogenic granuloma: a rare complication of silicone punctal plugs.
  149. Anterior segment indocyanine green angiography in scleral inflammation.
  150. Assessment of choroidal involvement in sarcoidosis with indocyanine green angiography.
  151. Retinal tears associated with panuveitis and Behçet's disease.
  152. Penetrating keratoplasty in patients with corneal scarring due to trachoma.
  153. Cataract surgery in patients with Fuchs' heterochromic iridocyclitis.
  154. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.
  155. [Pterygium excision with intra-operative administration of low dosage mitomycin C].
  156. Macular subretinal neovascular membrane associated with pseudotumor cerebri.
  157. Fleck dystrophy of the cornea; a report of cases from three generations of a family.
  158. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis.
  159. Patients satisfaction and clinical outcomes of binocular implantation of a new trifocal intraocular lens
Prof. Dr. Yonca Aydın AkovaSoru ve Randevu Formu
Basından
ANLAŞMALI KURUMLAR
Prof. Dr. Yonca Aydın AkovaPROF. DR. YONCA AYDIN AKOVAGöz Sağlığı ve Hastalıkları Uzmanı
0312 557 90000505 172 1717